Skip to main content

3137 WPI (Nizatidine 150 mg)

Pill with imprint 3137 WPI is White, Capsule-shape and has been identified as Nizatidine 150 mg. It is supplied by Watson Pharmaceuticals.

Nizatidine is used in the treatment of gerd; indigestion; erosive esophagitis; duodenal ulcer; duodenal ulcer prophylaxis and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Nizatidine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 3137 WPI


3137 WPI
150 mg
18.00 mm
Rx and/or OTC
Drug Class
H2 antagonists
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Pharmaceuticals
National Drug Code (NDC)
00591-3137 (Discontinued)
Inactive Ingredients
silicon dioxide, corn starch, croscarmellose sodium, magnesium stearate, ammonia, ferrosoferric oxide, gelatin, potassium hydroxide, propylene glycol, shellac, sodium lauryl sulfate, titanium dioxide, D&C Yellow No. 10, FD&C Yellow No. 6

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.